You are here

Big Pharma losing price leverage amid squeeze by payers

Latest quarterly results raise pressure on drugmakers to pump up sales volumes, find lucrative new treatments

BT_20170505_NSBIG5_2872745.jpg
Executives from Mylan NV, the maker of allergy shot EpiPen, and Valeant Pharmaceuticals International Inc were brought before Congress to explain what they charge.

New York

BEING a big drug company isn't what it used to be.

The largest drugmakers are finding it more difficult to charge high prices for a range of medications, their latest quarterly results show. That's raising the pressure to pump up sales volumes and find lucrative new

sentifi.com

Market voices on:

grab

Receive $80 Grab vouchers valid for use on all Grab services except GrabHitch and GrabShuttle when you subscribe to BT All-Digital at only $0.99*/month.

Find out more at btsub.sg/promo

Powered by GET.comGetCom